Skip to main content
. 2019 Apr 25;14(4):e0215920. doi: 10.1371/journal.pone.0215920

Table 1. Characteristics of participants according to sex and Hb categories.

Women Men
Hb group (g/dL) Subtotal ≥13 12–12.9 11–11.9 10–10.9 <10 Subtotal ≥15 14–14.9 13–13.9 12–12.9 <12
Variables Characteristics N = 233,497 n = 116,459 n = 81,339 n = 24,658 n = 6,884 n = 4,157 N = 277,123 n = 131,107 n = 92,508 n = 40,784 n = 9,700 n = 3,024
Age years 54.0 ±9.9 54.2±9.6 54.2±10.0 54.0±10.6 51.5±10.3 48.3±8.5 52.3 ±9.5 50.7±8.7 52.4±9.4 54.9±10.2 58.4±10.8 60.2±11.0
Body mass index kg/m2 24.0 ±3.1 24.3±3.1 23.8±3.0 23.4±3.0 23.3±3.0 23.4±3.0 24.0 ±2.8 24.5±2.8 23.8±2.8 23.3±2.9 22.6±2.9 22.1±3.1
Total cholesterol mg/dL 203 ±39 207±40 201±38 195±38 191±39 181±35 199 ±38 203±38 197±37 192±38 185±38 176±40
Smoking status Never smoker 216,135 (92.6) 92.2 92.9 93.1 93.3 93.1 111,678 (40.3) 38.0 41.2 43.9 45.7 46.4
Past smoker 2,152 (0.9) 1.0 0.9 0.8 0.9 0.9 41,262 (14.9) 14.7 15.4 14.4 13.9 14.2
Current smoker 6,398 (2.7) 3.1 2.5 2.3 2.1 1.8 111,450 (40.2) 42.7 38.8 37.0 35.4 34.4
Missing 8,812 (3.8) 3.8 3.7 3.9 3.7 4.2 12,733 (4.6) 4.6 4.6 4.7 4.9 5.0
Alcohol use, None 187,901 (80.5) 80.0 80.9 81.5 80.9 79.9 95,540 (34.5) 31.4 35.1 39.6 44.8 49.2
times/week <2 35,687 (15.3) 15.7 15.0 14.3 15.2 15.9 124,181 (44.8) 47.5 44.8 39.8 34.6 30.0
3–7 4,231 (1.8) 2.0 1.7 1.5 1.7 1.5 53,497 (19.3) 19.8 18.8 19.1 18.6 18.7
Missing 5,678 (2.4) 2.4 2.4 2.7 2.2 2.7 3,905 (1.4) 1.4 1.3 1.5 2.0 2.1
Physical activity ≥1 times/week 74,782 (32.0) 32.2 32.2 31.5 30.7 29.2 135,293 (48.8) 50.2 49.3 46.0 40.7 37.8
Income status, <4 (low income) 67,202 (28.8) 28.6 28.7 29.8 28.9 29.4 50,306 (18.2) 16.2 18.4 21.6 24.8 26.0
decile 4–7 75,124 (32.2) 32.5 32.1 31.6 31.7 29.1 91,149 (32.9) 31.6 33.1 35.3 37.4 35.0
>7 (high income) 91,171 (39.0) 38.9 39.2 38.6 39.4 41.5 135,668 (49.0) 52.2 48.4 43.2 37.8 39.1
Age group <60 years 160,118 (68.6) 68.5 67.6 67.0 75.9 87.8 209,137 (75.5) 81.7 75.1 64.6 50.7 43.4
≥60 years 73,379 (31.4) 31.5 32.4 33.0 24.1 12.2 67,986 (24.5) 18.3 24.9 35.4 49.3 56.6
Albuminuria No 225,173 (96.4) 96.3 96.7 96.6 95.7 95.8 267,344 (96.5) 96.2 97.0 96.6 95.2 93.4
Trace 3,688 (1.6) 1.6 1.5 1.5 2.0 1.3 4,294 (1.5) 1.6 1.4 1.5 1.8 1.8
1+ 3,172 (1.4) 1.5 1.2 1.2 1.5 1.6 3,603 (1.3) 1.5 1.0 1.2 1.9 2.1
2+ 1,157 (0.5) 0.5 0.5 0.4 0.6 1.0 1,460 (0.5) 0.6 0.4 0.5 0.8 2.0
≥3+ 307 (0.1) 0.1 0.1 0.1 0.2 0.4 422 (0.2) 0.1 0.1 0.2 0.3 0.7
Hematuria No 204,064 (87.4) 88.0 87.1 85.6 87.4 87.8 264,861 (95.6) 95.9 95.6 95.0 93.7 92.4
Trace 7,482 (3.2) 3.1 3.3 3.7 3.5 3.0 3,554 (1.3) 1.2 1.3 1.3 1.6 1.7
1+ 12,225 (5.2) 5.1 5.3 5.8 4.6 4.5 5,324 (1.9) 1.8 1.9 2.2 2.6 3.2
2+ 6,221 (2.7) 2.5 2.8 3.1 2.5 2.6 2,234 (0.8) 0.7 0.8 0.9 1.4 1.6
≥3+ 3,505 (1.5) 1.3 1.6 1.9 2.0 2.1 1,150 (0.4) 0.3 0.4 0.5 0.8 1.1
Comorbidity Diabetesa 22,906 (9.8) 11.0 8.9 8.4 7.9 6.4 34,362 (12.4) 12.4 11.6 12.9 15.5 19.7
Hypertensionb 75,715 (32.4) 35.9 30.0 28.1 24.9 20.1 96,350 (34.8) 35.6 33.5 34.2 37.4 39.2
Heart disease or strokec 4,858 (2.1) 2.2 2.0 2.0 1.8 1.4 4,736 (1.7) 1.5 1.6 2.1 2.8 3.2
Cancerc 1,604 (0.7) 0.6 0.7 0.8 0.8 0.8 1,258 (0.5) 0.2 0.4 0.7 1.8 3.8

Hb, hemoglobin

Data are expressed as mean ± standard deviation, n(%), or %.

P values, which were calculated by the chi-square test and 1-way analysis of variance between Hb groups, were < .001 for each variable, except for comorbid cancer in women (P = .006)

aPersons with known diabetes by hospital visit records or fasting glucose level ≥126 mg/dL at baseline health screening.

bPersons with known hypertension by hospital visit records or systolic blood pressure ≥140 mm Hg at baseline health screening.

cPersons with a history of the diseases via questionnaire